Episode 213 -- September 2024 -- Part 1 AFP: American Family Physician

The PREVENT calculator (1:30), hair loss (5:20), resmetirom (9:50), continuous vs. intermittent glucose monitoring (15:10), Cushing’s syndrome (17:10), and screening for lipid disorders in children and adolescents (23:10).

Management of obesity (1:45), diagnosing dementia (6:10), mastitis (9:10), the G2211 code (13:30), alcohol use in adolescents (16:10), and imaging guidelines for mild traumatic brain injury (18:20).

Conjunctivitis (1:40), measles (6:10), perioperative glycemic control (8:20), chronic cough (11:20), HPV vaccine preventing cervical cancer (15:10), and tirzepatide for treatment of obesity (18:10).

Cognitive enhancers and Mini-Mental State Examination (1:40), primary care of adult cancer survivors (4:00), bupropion for depression in adolescents (8:50), acute and chronic prostatitis (10:50), antibiotics in uncomplicated but febrile urinary tract infections (14:10), and top 20 research studies of 2023 (15:30).

Obstructive sleep apnea in adults (1:40), e-cigarettes (5:30), breastfeeding support for healthy mothers and infants (7:40), hematologic emergencies (10:20), midodrine for recurrent vasovagal syncope (15:30), and cranberry products for preventing urinary tract infections (17:20).

Testosterone therapy for male hypogonadism (1:40), avoiding judgmental clinical documentation (5:50), bipolar disorder (8:10), gallstone disease (11:40), bempedoic acid (15:50), and stable chronic obstructive pulmonary disease (18:40).

Lifelong care for patients after gender-affirming surgery (1:30), lipid management (6:10), carpal tunnel syndrome (11:10), spontaneous vaginal delivery (14:00), oseltamivir (17:20), and new medicines for RSV prevention (19:40).

Atrial fibrillation (1:30), sFlt-1/PlGF ratio in preeclampsia (4:50), hyaluronic acid for wounds (6:40), substance misuse (9:00), nirsevimab (12:50), and AFP Clinical Answers (14:10).

Acute pericarditis (1:30), saw palmetto for benign prostatic hyperplasia (5:30), baclofen for alcohol use disorder (8:00), nausea and vomiting (10:30), fecal microbiota spores for Clostridioides difficile (15:20), and monoclonal antibody therapy for Alzheimer disease (18:20).

Noninsulin therapy for type 2 diabetes mellitus (1:50), high-dose flu vaccine (4:40), remote psychotherapy for chronic pain (6:20), lumbar spinal stenosis (8:30), primary care access in areas with aging populations (12:40), and herbal medicines for functional dyspepsia (14:10).